Healthcare provider profile · identity verified

Mark R Mccabe, MD

Family Practice · FITCHBURG, WI · NPI 1407352537

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	215	61
Amlodipine Besylate	Amlodipine Besylate	132	40
Omeprazole	Omeprazole	113	32
Levothyroxine Sodium	Levothyroxine Sodium	109	26
Lisinopril	Lisinopril	106	34
Rosuvastatin Calcium	Rosuvastatin Calcium	103	31
Metformin Hcl Er	Metformin Hcl	82	21
Trazodone Hcl	Trazodone Hcl	78	16
Losartan Potassium	Losartan Potassium	74	18
Metoprolol Succinate	Metoprolol Succinate	67	22
Sertraline Hcl	Sertraline Hcl	67	11
Duloxetine Hcl	Duloxetine Hcl	62	14
Tamsulosin Hcl	Tamsulosin Hcl	62	19
Hydrochlorothiazide	Hydrochlorothiazide	61	18
Ozempic	Semaglutide	58	suppressed
Gabapentin	Gabapentin	54	12
Simvastatin	Simvastatin	48	14
Eliquis	Apixaban	46	12
Furosemide	Furosemide	46	14
Pantoprazole Sodium	Pantoprazole Sodium	45	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	44	14
Allopurinol	Allopurinol	38	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	suppressed
Naproxen	Naproxen	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Trulicity	Dulaglutide	34	suppressed
Valsartan	Valsartan	32	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Jardiance	Empagliflozin	28	suppressed
Metformin Hcl	Metformin Hcl	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Fluticasone Propionate	Fluticasone Propionate	26	17
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	13
Enalapril Maleate	Enalapril Maleate	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Glipizide	Glipizide	21	suppressed
Baclofen	Baclofen	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Carvedilol	Carvedilol	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Potassium Chloride	Potassium Chloride	16	suppressed
Atenolol	Atenolol	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Irbesartan	Irbesartan	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Mounjaro	Tirzepatide	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Cephalexin	Cephalexin	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Sulfasalazine	Sulfasalazine	12	suppressed
Clopidogrel	Clopidogrel Bisulfate	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Pregabalin	Pregabalin	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error